Category Archives: Clinical Collaborations

Highmark’s Strategy to Contain Drug Costs Includes an Increasing Number of Outcome-Based Contracts

Pharmaceutical manufacturers and payers have developed a number of agreements under which reimbursement is contingent on specific outcomes over the last few years

Heartline Study Increases Apple Research’s Clinical Trial Growth

New digital technologies offer a different approach to capturing, analyzing and predicting patient behavior.

ProofPilot Collaboration Increasing Access to Timely Research

The influx of new digital technologies has offered the clinical trial industry a systemized approach to collect and analyze patient behavior

Concerto HealthAI’s Focuses on Growing Opportunity for Real-World Analysis

Concerto HealthAI, offers a clinical insight generation platform that employs real-world data in its analyses

CVS Health Initiatives include Chronic Kidney Care

CVS’s objective is to place consumers at the center of its strategy and help them achieve their best health by strengthening health care locally and making it simpler to use and understand

OneOme Making Progress in Pharmacogenomics

Pharmacogenomics is one of the key aspects of personalized medicine, focusing on how an individual’s DNA affects the way they respond to medications. All individuals have different genetic make-up so they respond differently to the same medication. Based on this insight, pharmacogenomics allows customized treatment for a wide range of health problems including; cardiovascular disease, […]

AetnaCare Boosted by Merck Collaboration

AetnaCare Boosted by Merck Collaboration: Aetna has announced AetnaCare℠, a new program designed to offer members an integrated care plan so they have the knowledge, motivation and confidence to manage their own health. Over 40% of Aetna’s medical spend currently runs through some form of value-based care model today and the company is developing programs like […]

Increasing Demand for Drug Based Outcomes

Specialty Pharma Services

Increasing Demand for Drug Based Outcomes – Outcome-based contracts are a relatively new and growing contracting methodology focused on shifting reimbursement from volume to value. The contracts are between a health plan and manufacturer where reimbursement is dependent on pre-defined outcome metrics focused on improving patient responses/health. Currently, the relationship between the pharmaceutical manufacturer, the […]